Integrated acoustic dispensing and droplet microfluidics accelerate gene editing workflows
16 Feb 2024
Explore an innovative high-throughput CRISPR screening workflow in drug discovery with Hugo Sinha, co-founder and COO of DropGenie. Its microfluidic platform is designed to reduce cellular input while maintaining efficiency and viability for genome-wide screening. Integrated automation enables thousands of edits per day, enhancing the efficiency and cost-effectiveness of drug discovery. In this video, Sinha demonstrates low-volume, high-throughput discovery using the Echo 655T and Biomek i7 hybrid liquid handlers form Beckman Coulter Life Sciences paired with the DropGenie platform.
This video was filmed at SLAS2024.
About the company
Beckman Coulter Life Sciences
Since 1935, the Beckman name has been synonymous with technologies that simplify and automate lab research and complex biomedical testing. Decades later, our global organization also came to embody the scientific legacy of the Coulter name. Today, Beckman Coulter Life Sciences is a trusted, worldwide resource for tools to help optimize research and manufacturing efficiency. Centrifuges. Particle counters/analyzers. Automated liquid handlers. Flow cytometers. All these products—and many more—continue to make a difference in people’s lives by improving the productivity of dedicated scientists, quality control experts and others. Visit beckman.com to learn more.
